• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

The inventory of GRAS notices provides information about GRAS notices filed since 1998, when FDA received its first GRAS notice. As of October 17, 2016, the GRAS final rule (81 FR 54960; August 17, 2016) requires a specific format for a GRAS notice. Prior to that date, FDA processed GRAS notices under the framework of the GRAS proposed rule (62 FR 18938; April 17, 1997). Notices received prior to the effective date of the GRAS final rule provide examples for potential notifiers for the types of information that may support a GRAS conclusion. In the inventory, notices follow the requirements for the format and content of a GRAS notice as of the effective date of the GRAS final rule.

We will update this information approximately monthly. More information about this inventory is available on the GRAS Notice Inventory Introduction page.


Search and display hints:

  • Select the specific GRN number below to view additional details about any GRAS Notice.
  • To sort by a specific field, click on the column header for that field.
  • To browse the records, use the Show All, First/Previous/Next/Last, and Jump To options at the bottom of the data table.
  • To search for a specific substance/term, enter the term in the Search box and select Show Items to display only those records that contain the selected term. (The search results also includes terms not shown on this page, but included in the full record on the detail page.)
  • The search results will return hits of records containing words that include the search term. For example, a search for the color red will return results that include terms such as reduce, ingredient, and cultured. To limit results to only the searched term, place a space before and after the word in the basic search or in the advanced search “this exact phrase” field.
Search within these results
Records Found: 917 Show All Page 1 of 19
GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter
917 Preparation containing three bacterial phages specific to Salmonella Pending
916 Dihydroquercetin Pending
915 Calcium L-methylfolate Pending
914 Alpha-linolenic acid diacylglycerol Pending
913 Algal oil (minimum 35% DHA) Pending
912 Trehalose Pending
911 Rebaudioside I Pending
910 Thaumatin II produced in Nicotiana benthamiana Pending
909 Whey protein containing 41% alpha-lactalbumin Pending
908 Lipase from Penicillium camemberti Pending
907 Wheat seed oil Pending
906 Wheat polar lipids Pending
905 Bacillus subtilis SG188 Jun 8, 2020 FDA has no questions (in PDF) (659 kB)
904 Fusarium novum. yellowstonensis mycelium Pending
903 Quillaia extract type 2 Pending
902 Neohesperidin dihydrochalcone Pending
901 Glucosyl hesperidin Pending
900 Corn oil Pending
899 Citric acid esters of mono- and diglycerides Pending
898 Dried milk fat Pending
897 2’-O-fucosyllactose Pending
896 Alpha-galacto-oligosaccharides Pending
895 Lacto-N-neotetraose Pending
894 White mulberry leaf extract Pending
893 D-psicose Jun 5, 2020 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (58 kB)
892 Refined shea butter Pending
891 Cellulase produced by Trichoderma reesei Pending
890 Corn oil derived from distillers grains Pending
889 Wheat germ extract Pending
888 Preparation containing three bacterial phages specific to Salmonella Feb 28, 2020 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (36 KB)
887 Menaquinone-7 FDA has no questions (in PDF) (472 kB)
886 Monoacylglycerides from grape seed Pending
885 Vinyl acetate-vinyl laurate copolymer Pending
884 Rice bran extract Pending
883 Ilex guayusa leaf aqueous extract Apr 28, 2020 FDA has no questions (in PDF) (46 KB)
882 Rebaudioside M Pending
881 6’-sialyllactose sodium salt Apr 13, 2020 FDA has no questions (in PDF) (562 kB)
880 3’-sialyllactose sodium salt Apr 13, 2020 FDA has no questions (in PDF) (557 kB)
879 Fava bean protein isolate Mar 23, 2020 FDA has no questions (502 KB)
878 Glucosylated steviol glycosides Pending
877 Bifidobacterium longum BB536 Dec 26, 2019 FDA has no questions (in PDF) (75 KB)
876 Hydroxytyrosol Jan 21, 2020 FDA has no questions (in PDF) (88 KB)
875 Bifidobacterium animalis subsp. lactis AD011 Pending
874 Corn protein Apr 29, 2020 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (44 KB)
873 Cranberry extract May 6, 2020 FDA has no questions (in PDF) (567 KB)
872 Bifidobacterium animalis subsp. lactis UABla-12 Dec 9, 2019 FDA has no questions (in PDF) (62 KB)
871 Lactobacillus acidophilus DDS-1 Oct 23, 2019 FDA has no questions (in PDF) (49 KB)
870 Ilex guayusa leaf hydroethanolic extract Mar 20, 2020 FDA has no questions (in PDF) (550 MB)
869 Ilex guayusa leaf aqueous extract Mar 20, 2020 FDA has no questions (in PDF) (550 KB)
868 Coffee fruit extract Mar 24, 2020 FDA has no questions (in PDF) (556 kB)

Show All 

jump to page of 19 


GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter

679662  

-
-